Clinical Trial Update: LRFN5 and OLFM4 in Methamphetamine-Induced Psychosis

View source ↗

Summary

A clinical trial is investigating the roles of LRFN5 and OLFM4 in methamphetamine use disorder and methamphetamine-induced psychosis, and the study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Use Disorder
• Methamphetamine-induced Psychosis

Snippet

Sponsor: Elazığ Mental Health and Diseases Hospital | Conditions: Methamphetamine Use Disorder, Methamphetamine-induced Psychosis | Status: RECRUITING